Peter Vestergaard
Overview
Explore the profile of Peter Vestergaard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
408
Citations
5740
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Matthesen A, Rosendal C, Christensen E, Beckmann H, Klit F, Nikontovic A, et al.
Pituitary
. 2025 Mar;
28(2):42.
PMID: 40082297
Purpose: We aimed to evaluate the risk of psychiatric disorders through a retrospective cohort study comparing acromegaly and non-functioning pituitary adenomas (NFPAs) and a meta-analysis of existing literature. Methods: The...
2.
Hansen A, Vestergaard P, Poulsen M, Rasmussen A, Feldt-Rasmussen U, Madsen M, et al.
Cancers (Basel)
. 2025 Feb;
17(3).
PMID: 39941743
: Multiple endocrine neoplasia type 2A (MEN 2A) is a rare hereditary cancer syndrome caused by pathogenic variants in the rearranged during transfection () gene and is characterized by medullary...
3.
Borbjerg M, Wegeberg A, Nikontovic A, Morch C, Arendt-Nielsen L, Ejskjaer N, et al.
Diabetes Care
. 2025 Feb;
PMID: 39932781
Objective: Diabetic peripheral neuropathy (DPN) and neuropathic pain impacts quality of life (QoL) and mental health negatively. This cross-sectional survey study aimed to 1) elucidate the associations between painful and...
4.
Hansen A, Christiansen C, Brons C, Engelhard L, Hansen T, Nielsen J, et al.
Diabetologia
. 2025 Feb;
PMID: 39891704
Aims/hypothesis: Low birthweight (LBW) is associated with younger age, less obesity and more hypertension among people recently diagnosed with type 2 diabetes, as well as increased cardiovascular morbidity and mortality...
5.
Thomsen C, Kronborg T, Hangaard S, Vestergaard P, Jensen M
Int J Med Inform
. 2025 Jan;
195:105783.
PMID: 39787659
Background And Aim: The progressive nature of type 2 diabetes often, in time, necessitates basal insulin therapy to achieve glycemic targets. However, despite standardized titration algorithms, many people remain poorly...
6.
Hansen A, Andersen M, Engelhard L, Brons C, Hansen T, Nielsen J, et al.
Diabetes Obes Metab
. 2025 Jan;
27(4):2002-2011.
PMID: 39780311
Aims: TCF7L2 rs7903146 is the most impactful single genetic risk variant for type 2 diabetes. However, its role on disease progression, complications and mortality among people with type 2 diabetes...
7.
Kjaergaard A, Vaag A, Jensen V, Olsen M, Hojlund K, Vestergaard P, et al.
Diabetes Res Clin Pract
. 2024 Dec;
219():111970.
PMID: 39719182
Aims: We investigated the association of the inflammatory biomarker YKL-40 with cardiovascular events (CVEs) and mortality in individuals with type 2 diabetes. Methods: We followed 11,346 individuals recently diagnosed with...
8.
Thomsen C, Kronborg T, Hangaard S, Vestergaard P, Hejlesen O, Jensen M
Int J Med Inform
. 2024 Dec;
195:105758.
PMID: 39705917
Introduction: Optimal basal insulin titration for people with type 2 diabetes is vital to effectively reducing the risk of complications. However, a sizeable proportion of people (30-50 %) remain in...
9.
Kristensen F, Domazet S, Nielsen J, Stidsen J, Hojlund K, Beck-Nielsen H, et al.
Diabetologia
. 2024 Dec;
68(3):576-587.
PMID: 39663235
Aims/hypothesis: A better understanding of the mechanisms underlying an elevated infection risk in individuals with type 2 diabetes is needed to guide risk stratification and prevention. We investigated the risk...
10.
Norlev J, Kronborg T, Jensen M, Vestergaard P, Hejlesen O, Hangaard S
J Diabetes Sci Technol
. 2024 Nov;
:19322968241296828.
PMID: 39523580
Background: The study aimed to determine the relationship between basal insulin adherence and glycemic control evaluated by time in range (TIR) in people with insulin-treated type 2 diabetes (T2D), using...